Business Wire

Vertex Appoints Jonathan Biller as Chief Legal Officer

Share

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Jonathan Biller has been appointed Chief Legal Officer, effective September 19, 2022. Mr. Biller will report directly to Vertex’s Chief Executive Officer and President, Reshma Kewalramani, M.D., and join the company’s Executive Committee. In this role, Mr. Biller will oversee all of Vertex’s global legal and compliance functions.

“Jonathan is an outstanding addition to Vertex with his deep legal, industry and business experience, and I am delighted to welcome him to the company,” said Dr. Kewalramani. “Jonathan will lead an extraordinarily talented legal and compliance team and support our continued growth as we expand our leadership in cystic fibrosis, advance the pipeline across multiple diseases and modalities, and invest in the next wave of innovation.”

Mr. Biller joins Vertex from Agios, where he served in several executive roles including Chief Legal Officer and most recently Chief Financial Officer and Head of Corporate Affairs. Prior to this, he served as Executive Vice President, General Counsel at Celgene, where he was responsible for their global legal function, and before that as Senior Vice President, Tax and Treasury. Prior to Celgene, Mr. Biller was General Counsel, Chief Tax Officer and Secretary at Bunge Limited, a publicly traded agriculture and food company, and held roles of increasing responsibility at Alcon, Inc. during which time it was a publicly traded company. He began his legal career at Hopkins & Sutter rising to the level of partner and was also partner at Foley & Lardner after the firms merged. He holds a B.A. degree from Brown University and a J.D. from Yale Law School.

“Vertex has a highly differentiated strategy, a special culture that resonates with me, an impressive track record of success, and the potential to truly transform the treatment of multiple serious diseases. I am thrilled to have the opportunity to join the company at such an exciting time and work with such talented and committed colleagues to help build the company for the future,” said Mr. Biller.

About Vertex

Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has multiple approved medicines that treat the underlying cause of cystic fibrosis (CF) — a rare, life-threatening genetic disease — and has several ongoing clinical and research programs in CF. Beyond CF, Vertex has a robust pipeline of investigational small molecule, cell and genetic therapies in other serious diseases where it has deep insight into causal human biology, including sickle cell disease, beta thalassemia, APOL1-mediated kidney disease, pain, type 1 diabetes, alpha-1 antitrypsin deficiency and Duchenne muscular dystrophy.

Founded in 1989 in Cambridge, Mass., Vertex's global headquarters is now located in Boston's Innovation District and its international headquarters is in London. Additionally, the company has research and development sites and commercial offices in North America, Europe, Australia and Latin America. Vertex is consistently recognized as one of the industry's top places to work, including 12 consecutive years on Science magazine's Top Employers list and one of the 2021 Seramount (formerly Working Mother Media) 100 Best Companies. For company updates and to learn more about Vertex's history of innovation, visit www.vrtx.com or follow us on Facebook, Twitter, LinkedIn, YouTube and Instagram.

Special Note Regarding Forward-Looking Statements

This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, including, without limitation, the statements in the second and fourth paragraphs of this press release. While Vertex believes the forward-looking statements contained in this press release are accurate, these forward-looking statements represent the company's beliefs only as of the date of this press release and there are a number of risks and uncertainties that could cause actual events or results to differ materially from those expressed or implied by such forward-looking statements. Those risks and uncertainties include, among other things, the risks listed under the heading “Risk Factors” in Vertex's most recent annual report filed with the Securities and Exchange Commission (SEC) and available through the company's website at www.vrtx.com and on the SEC’s website at www.sec.gov. You should not place undue reliance on these statements. Vertex disclaims any obligation to update the information contained in this press release as new information becomes available.

(VRTX-GEN)

Source: Vertex Pharmaceuticals Incorporated

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Vertex Pharmaceuticals Incorporated
Investors:
InvestorInfo@vrtx.com
or
Manisha Pai: 617-961-1899
or
Miroslava Minkova: 617-341-6135
Media:
mediainfo@vrtx.com
or
U.S.: +1 617-341-6992
or
Heather Nichols: +1 617-839-3607
or
International: +44 20 3204 5275

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Mercans Adds Industry Veteran Steve Goldberg to its Board4.10.2022 16:07:00 CEST | Press release

Mercans, the global payroll technology leader, has announced that Steve Goldberg has joined its board as a non-executive director. The addition of an industry veteran to Mercans’ board follows several recently announced corporate governance changes to strengthen the board and executive management team of the global payroll and EOR service provider. When announcing Steve Goldberg’s appointment, Mercans’ board said,“We welcome Steve as a non-executive director to the board and believe that his long-term industry experience and insights will bring unique perspectives to Mercans. Steve’s strategic vision for the global payroll and HCM industry aligns well with Mercans’ strategy. We are confident that his leadership will further accelerate Mercans’ growth and strengthen its ability to deliver award-winning global payroll technology.” Steve Goldberg's 30+ year career on all sides of HR and Payroll technology includes HR executive roles across 3 continents, serving as HCM product strategy lea

Announcing ClickHouse Cloud: Democratizing lightning-fast insights and analytics4.10.2022 16:00:00 CEST | Press release

Today, ClickHouse, Inc. announced the launch of ClickHouse Cloud, a lightning-fast cloud-based database that simplifies and accelerates insights and analytics for modern digital enterprises. With no infrastructure to manage, ClickHouse Cloud architecture decouples storage and compute and scales automatically to accommodate modern workloads, so users do not have to size and tune their clusters to achieve blazing-fast query speeds. Historically, data infrastructure and analytics solutions have been expensive and difficult to manage. Companies frequently bore the expense of specialized experts and infrastructure teams, only to receive unacceptable performance in return, as legacy solutions struggled to scale. The introduction of ClickHouse Cloud, built by the creators of the much-loved open source project, brings enterprise-grade data analytics and lightning-fast insights to the masses. A ClickHouse Cloud user can log in and launch a new service with a few clicks, and start analyzing thei

GlobalLogic Inaugurates Two New Engineering Centers in Mexico4.10.2022 15:00:00 CEST | Press release

GlobalLogic Inc., a Hitachi Group company and Digital Engineering leader, today announced the opening of two new engineering and sales centers in Mexico. The centers will be located at Guadalajara and Mexico City. The expansion will help GlobalLogic meet the robust demand for digital solutions, as companies across industries and around the globe continue to transform their products and digital experiences to better engage their customers, access new revenue streams, and make their offerings more sustainable. The sites expand on GlobalLogic’s existing Latin American presence, which includes engineering and sales centers in Argentina and Chile. “We have executed on a steady expansion campaign for years, identifying gaps in the market and pairing those with emerging customer hubs,” said Vishal Anand, Group Vice President & Head of Americas, GlobalLogic. “The LatAm region is a critical component of that growth strategy as our clients look to offer differentiated products and services along

Expensify Gives Accountants a Chance to Win Their Spot at ExpensiCon in Italy4.10.2022 15:00:00 CEST | Press release

Expensify, Inc. (Nasdaq: EXFY), a payments superapp that helps individuals and businesses around the world simplify the way they manage money across expenses, corporate cards and bills, today announced the “Win your spot at ExpensiCon” contest. The contest is open to any accountant, but only five accountants will win a spot at this exclusive, invite-only conference for themselves and a guest. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221004005072/en/ “We’re bringing together 100 of the industry’s best and brightest, and five of the most coveted spots in accounting are now available to any accountant from any size firm,” says David Barrett, founder and CEO of Expensify. “This is an unparalleled opportunity to join a global community of accounting leaders with hundreds of years of combined experience to plan for the next generation of the profession. Together, we can identify and solve the most complex challenges that wil

INNIO‘s next generation Jenbacher 3F engine offers significantly higher efficiency4.10.2022 14:07:00 CEST | Press release

INNIO announced today that it has launched its next generation Jenbacher Type 3F engine. This forms part of INNIO’s commitment to empower the transition to net zero with flexible, scalable, and resilient energy solutions and services. The new and improved Jenbacher Type 3F engine offers customers proven robustness and reliability while delivering up to two percentage points of efficiency boost, the engine line’s highest efficiency ever. In addition to delivering efficiency as high as 43.3% when operating on pipeline gas, the Type 3F engine is optimized for reduced total hydrocarbon (THC) emissions, future-proofed fuel flexibility, and enhanced serviceability. Moreover, the latest 3F technology is offered with a “Ready for H2” option and retrofittable for most of the installed Type 3 fleet. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221004005681/en/ INNIO's next generation Jenbacher Type 3F engine has the line's highest e